COMPARISON OF THE RATE OF SEQUENCE VARIATION IN THE HYPERVARIABLE REGION OF E2 NS1 REGION OF HEPATITIS-C VIRUS IN NORMAL AND HYPOGAMMAGLOBULINEMIC PATIENTS/
Jcl. Booth et al., COMPARISON OF THE RATE OF SEQUENCE VARIATION IN THE HYPERVARIABLE REGION OF E2 NS1 REGION OF HEPATITIS-C VIRUS IN NORMAL AND HYPOGAMMAGLOBULINEMIC PATIENTS/, Hepatology, 27(1), 1998, pp. 223-227
The hypervariable region (HVR) of the E2/NS1 region of hepatitis C vir
us (HCV) varies greatly between viral isolates with high rates of geno
mic change reported during the course of chronic infection. The HVR is
thought to encode a structurally unconstrained ent elope protein cont
aining several linear B cell epitopes recognized by neutralizing antib
ody. It has been postulated that amino acid changes in the HVR could r
esult from humoral immune pressure leading to the selection of escape
mutants. The aim of this study was to compare the rates of nucleotide
and amino acid variation in the HVR of control patients to patients wi
th common variable immunodeficiency (CVID) where the effect of the hum
oral immune system is reduced, Five controls and four patients with CV
ID were studied, Serum samples were taken over periods of between 1 an
d 6 years, HCV was detected by polymerase chain reaction (PCR) with pr
imers derived from conserved flanking regions of the HVR. PCR products
were cloned into a plasmid vector and recombinant clones identified b
y restriction enzyme digestion. Purified DNA from at least three indiv
idual clones from each time point was sequenced by the dideoxynucleoti
de chain-termination method. Consensus sequences were extracted from t
he three clones, and the DNA and deduced protein sequences were compar
ed. Control patients had a mean rate of nucleotide change of 6.954 nuc
leotide substitutions per year, compared with patients with CVID with
a rate of 0.415 nucleotide substitutions per year (P <.02), The corres
ponding rates for amino acid variation were 3.868 amino acid substitut
ions per year for the control patients compared with 0.185 amino acid
substitutions per year for the patients with CVID. These findings sugg
est that in the absence of humoral immune selective pressure, the freq
uency of occurrence of genetic variation in the major viral species is
reduced. The mutations occur, but in the absence of immune selection
remain as minor species, The evolution of viral mutants capable of eva
ding the host's immune system may contribute to the ability of HCV to
establish chronic infection.